We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+26.38%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$140B
AUM Growth
+$23.9B
Cap. Flow
-$1.4B
Cap. Flow %
-1%
Top 10 Hldgs %
16.71%
Holding
4,310
New
356
Increased
1,988
Reduced
1,282
Closed
383

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.02B
2
AMZN icon
Amazon
AMZN
+$922M
3
AAPL icon
Apple
AAPL
+$920M
4
OTIS icon
Otis Worldwide
OTIS
+$525M
5
TCOM icon
Trip.com Group
TCOM
+$523M

Sector Composition

Rank Sector Weight
1 Technology 17.27%
2 Healthcare 11.06%
3 Consumer Discretionary 9.06%
4 Financials 8.78%
5 Communication Services 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
G icon
3001
Genpact
G
$6.07B
$747K ﹤0.01%
20,455
-24,945
-55% -$843K
VTI icon
3002
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
$747K ﹤0.01%
4,774
-3,273
-41% -$483K
CGEN icon
3003
Compugen
CGEN
$216M
$746K ﹤0.01%
+49,643
New +$670K
WYNN icon
3004
CALL
Wynn Resorts
WYNN
$10.5B
$745K ﹤0.01%
10,000
-1,000
-9% -$80.2K
SCHL icon
3005
Scholastic
SCHL
$801M
$744K ﹤0.01%
24,859
+1,868
+8% +$53.8K
CRVL icon
3006
CorVel
CRVL
$3.19B
$742K ﹤0.01%
31,389
+8,946
+40% +$176K
HSKA
3007
DELISTED
Heska Corp
HSKA
$741K ﹤0.01%
7,952
-1,536
-16% -$118K
CBZ icon
3008
CBIZ
CBZ
$2.97B
$740K ﹤0.01%
30,872
-53,300
-63% -$1.21M
BLUE
3009
PUT
DELISTED
bluebird bio
BLUE
$739K ﹤0.01%
+934
New +$704K
GRVY
3010
GRAVITY
GRVY
$432M
$739K ﹤0.01%
+13,389
New +$598K
KALU icon
3011
Kaiser Aluminum
KALU
$2.91B
$738K ﹤0.01%
10,017
-2,441
-20% -$174K
AVTA
3012
DELISTED
Avantax, Inc. Common Stock
AVTA
$736K ﹤0.01%
64,436
+25,269
+65% +$317K
DVY icon
3013
iShares Select Dividend ETF
DVY
$23.5B
$733K ﹤0.01%
9,082
-6,650
-42% -$531K
AZZ icon
3014
AZZ Inc
AZZ
$4.57B
$732K ﹤0.01%
21,324
+713
+3% +$21.8K
CAG icon
3015
PUT
Conagra Brands
CAG
$7.18B
$732K ﹤0.01%
20,800
IMVP
3016
Invesco India ETF
IMVP
$115M
$731K ﹤0.01%
42,781
+13,200
+45% +$207K
FXD icon
3017
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
$729K ﹤0.01%
19,499
MBI icon
3018
MBIA
MBI
$268M
$729K ﹤0.01%
100,678
+15,559
+18% +$113K
LUV icon
3019
PUT
Southwest Airlines
LUV
$23.9B
$728K ﹤0.01%
21,300
+14,600
+218% +$464K
MMI icon
3020
Marcus & Millichap
MMI
$1.18B
$725K ﹤0.01%
25,131
+11,071
+79% +$312K
RMAX icon
3021
RE/MAX Holdings
RMAX
$207M
$721K ﹤0.01%
22,949
+9,014
+65% +$239K
MLAB icon
3022
Mesa Laboratories
MLAB
$574M
$718K ﹤0.01%
3,310
+691
+26% +$159K
HA
3023
DELISTED
Hawaiian Holdings, Inc.
HA
$717K ﹤0.01%
51,044
+19,765
+63% +$269K
KTB icon
3024
Kontoor Brands
KTB
$4.62B
$716K ﹤0.01%
40,193
+2,502
+7% +$44.6K
PDLI
3025
DELISTED
PDL BioPharma, Inc.
PDLI
$714K ﹤0.01%
245,313
+183,654
+298% +$581K

Similar funds

Credit Suisse's Q2 2020 Portfolio in Review

As of Q2 2020, Credit Suisse held 4,310 positions worth $140B, up 21% from $116B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse's Q2 2020 filing shows 356 new, 1,988 increased, 1,282 reduced and 383 closed positions. Its largest new stake was Otis Worldwide: 10,131,011 shares worth $576M. The largest sale was Allergan plc, an estimated $1.9B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Credit Suisse's largest Q2 2020 buy was Otis Worldwide: 10,131,011 shares worth $576M.
  • Credit Suisse added most to Microsoft in Q2 2020, an estimated $1.02B increase.
  • Credit Suisse's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $942M.
  • Credit Suisse fully exited Allergan plc in Q2 2020, selling an estimated $1.9B.
  • Credit Suisse's ten largest holdings make up 17% of its $140B portfolio in Q2 2020.
  • Credit Suisse opened 356 new positions and closed 383 in Q2 2020.
  • Credit Suisse's portfolio value rose 21% quarter-over-quarter to $140B.

Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.